HOW FABHALTA WORKS
For adults with primary IgAN at risk of disease worsening
FABHALTA: a first-of-its-kind targeted IgAN treatment
FABHALTA is the first and only FDA-approved oral treatment in IgAN that targets the alternative complement pathway, a part of the immune system
In immunoglobulin A nephropathy (IgAN), unwanted IgA antibodies build up in your kidneys, leading to the activation of multiple pathways including a part of your immune system called the alternative complement pathway.
FABHALTA is not a steroid. FABHALTA inhibits a part of the immune system called the complement system.
FABHALTA results
Download the patient brochure to learn more and ask your doctor if FABHALTA could be right for you